India Patent Cases
2,823 decisions indexed
Page 60 of 95 · 2,823 total
Preeti / Kosmos Global v.Suresh R. Jain
This case involved allegations by Preeti (Kosmos Global) against Suresh R. Jain for infringing their registered copyright and passing off their hair colour products under the trademark 'BEAUTE BLANC'. The dispute centered on the defendant's use of a similar pack/carton design and the name 'Skenique'. Ultimately, both parties reached a settlement agreement, leading to the court decreeing the suit based on the terms of the joint memo.
M/s.R.K.Ganapathi Chettiar v.Kothai Dairy Farm
M/s.R.K.Ganapathi Chettiar filed a suit against Kothai Dairy Farm and others alleging infringement of their trademarks and copyrights related to the product 'ghee'. The plaintiff sought permanent injunctions, damages, and rendition of accounts due to alleged passing off and unauthorized use of artistic works and trade dress. Ultimately, the parties reached a Joint Compromise Memo on 21.03.2022, which was subsequently decreed by the Madras High Court.
Merck Sharp And Dohme Corp v.Mr. Mahaveer Chand
The contempt petition was filed by Merck Sharp And Dohme Corp alleging non-compliance with a previous court order and settlement agreement concerning patent IN' 816. The petitioner claimed that the respondent continued dealing in products covered by the patent, specifically generic versions of Sitagliptin Phosphate Monohydrate. The Court directed the respondent to file an affidavit with an unconditional apology.
Dr. Reddy's Laboratories Limited & Anr. v.The Controller Of Patents & Ors.
This judgment addressed an application seeking dismissal of a patent revocation petition on the ground that it was barred by limitation. The court examined Section 64 of the Patents Act and the concept of a 'person interested'.
Daewoong Pharmaceutical Co. Ltd. v.Controller General Of Patents Designs And Trademarks
Daewoong Pharmaceutical appealed the rejection of its Indian Patent Application (No.201817048074), which covered a crystalline form of compound c28. The rejection was based on Section 3(d) of the Patents Act, 1970, as the drug was considered known and lacked enhanced therapeutic efficacy. Daewoong sought to introduce additional data demonstrating superior properties like stability and dissolution rates. The High Court accepted the application for additional documents but framed two critical issues: whether this post-filing data is admissible, and if the crystalline form ultimately meets Section 3(d) requirements.
Torrent Pharma Limited v.Controller General Of Patents
Torrent Pharma Limited filed an appeal challenging the order dated February 1, 2021, passed by the Assistant Controller. The said order rejected the patent application for 'Use of a Thiazolo Pyrimidinone' on grounds of lack of inventive step and non-patentability under Sections 3(e) and 3(d) of the Patents Act.
SOTKON SP SLU v.WESTERN IMAGINARY TRANSCON PVT. LTD.
The case involves the alleged infringement of the Plaintiff's patent and copyright rights related to a waste management system. The Defendants are accused of infringing the Plaintiff's patent by submitting a tender for a similar waste management technology.
Pfizer Products Inc v.D Rawal
The contempt petition was filed by Pfizer Products Inc alleging non-compliance with a previous court order. The respondent submitted an affidavit stating that they had applied to the DCGI for permission to manufacture and market the new drug, Tofacitinib, under New Drugs and Clinical Trial Rules, 2019. They undertook not to commercialize the product until the patent expiry date.
Dr. Sapna Nangia v.The Assistant Controller of Patents and Designs
Dr. Sapna Nangia filed an appeal challenging the Assistant Controller of Patents and Designs' order dated January 29, 2021. The original patent application (No. 201911010599) for a device and process was rejected primarily on the ground of lacking inventive step.
Bristol-Myers Squibb Holdings Ireland Unlimited Company v.Ms Glowsun India Labs Private Limited
Bristol-Myers Squibb filed a suit seeking permanent injunction against Ms Glowsun India Labs for infringing its patent (IN 247381) related to the drug APIXABAN. The parties subsequently resolved their dispute amicably through mediation, leading to a final settlement.
Ferring B.V. v.Precise Bio Pharma Pvt. Ltd.
Ferring B.V. filed a suit alleging infringement of Patent IN 387567, which covered RTS Carbetocin for preventing post-partum haemorrhage. The Plaintiffs argued that manufacturing occurred while the patent was validly granted in February 2022. However, the court found merit in the Defendants' contention that since the grant order was subsequently set aside by a writ petition, there was no valid patent to sustain the infringement suit.
Novartis AG v.Medipol Pharmaceuticals India Pvt Ltd
Novartis AG filed a suit seeking permanent injunction against Medipol Pharmaceuticals India Pvt Ltd and Metrochem Api Private Limited for infringing its patent (No. 233161) covering 'Eltrombopag Olamine', the API in Revolade. The court found that both defendants acknowledged the validity of the patent and admitted they had not manufactured or commercially sold the patented product, leading to a decree granting permanent injunction during the patent's term.
Ab Initio Technology Llc v.Assistant Controller Of Patents And Designs
The Appellant filed an appeal challenging the rejection of its patent application (No. 6500/DELNP/2011). The court first condoned a delay of 53 days in filing the appeal, and subsequently granted further time to the Respondent to file their reply.
Boehringer Ingelheim Pharma Gmbh And Co. Kg v.Natco Pharma Limited
The judgment addresses multiple applications within a commercial suit concerning pharmaceutical patents. The court disposed of an application regarding electronic records and issued directions on several other pending matters, including contempt proceedings related to the sale of Afatinib tablets.
Chugai Seiyaku Kabushiki Kaisha v.Controller Of Patents And Design
Chugai Seiyaku Kabushiki Kaisha appealed the rejection of its patent application (No. 201617023236) for a solid preparation containing Tofogliflozin in monohydrate crystal form. The Controller rejected the application, citing lack of inventive step and falling under Section 3(d) because it was merely a new use/form of a known drug without enhanced efficacy.
Macleods Pharmaceuticals Ltd v.The Controller Of Patents & Anr.
The court addressed two matters concerning the revocation of Indian Patent No. 243301, which covers the compound Linagliptin. The proceedings involved procedural steps such as treating a plaint as a petition and returning counter statements under objections.
Vifor (International) Ltd v.Hetero Healthcare Limited
Vifor (International) Ltd filed suit against Hetero Healthcare Limited alleging infringement of its patented drug, FERRIC CARBOXYMALTOSE. Vifor contended that Hetero was preparing to launch a generic version under the brand HETROFER, which infringed upon their exclusive patent rights for treating iron deficiency anaemia. The Delhi High Court examined the prima facie case and balance of convenience presented by the Plaintiffs.
Novartis Ag v.Msn Laboratories Pvt. Ltd
The case involves Novartis AG seeking a permanent injunction against MSN Laboratories Pvt. Ltd. for infringing its patent related to Eltrombopag Olamine, the active ingredient in its drug Revolade.
Chia Tai Tianqing Pharmaceutical Group Co. Ltd v.The Controller of Patents and Designs
The suit was filed by Chia Tai Tianqing Pharmaceutical Group challenging an impugned order from the Assistant Controller of Patents & Designs. The rejection was based on Section 2(1)(ja), Section 3(d), and Section 10 of the Patents Act, 1970. The plaintiff argued that the objections under Section 10 were never raised during examination and that deleted claims were improperly used for rejection.
Ischemix Llc v.The Controller Of Patents
Ischemix Llc appealed the rejection of its Indian Patent Application No.4380/DELNP/2013 by the Controller of Patents, which was based on Section 3(d) of the Patents Act, 1970. The appellant challenged the basis and citation of the prior art documents used against them.
Agriboard International Llc v.Deputy Controller Of Patents And Designs
Agriboard International LLC appealed the Deputy Controller's order refusing its patent application for 'Efficient Method and Apparatus for Producing Compressed Structural Fiberboard' on grounds of lack of inventive step. The petitioner argued that the refusal was cryptic and lacked proper reasoning regarding the differences between the subject invention and the cited prior art (D1).
Pfizer Inc & Ors v.Azista Industries Private Limited & Ors
Pfizer Inc and others filed a suit seeking permanent injunction, damages, and rendition of accounts against Azista Industries Private Limited and others for infringing their patented drug 'Palbociclib'. The court found that the Plaintiffs had made out a prima facie case for an ad-interim ex parte injunction.
UPL Limited v.Agro King Pesticides Pvt. Ltd.
The dispute involved UPL Limited asserting its patent rights over the composition Clodinafop-Propargyl (15%) + Metsulfuron Methyl (1%) WP against Agro King Pesticides Pvt. Ltd. The matter was amicably settled before the Delhi High Court Mediation and Conciliation Centre.
Eli Lilly And Company v.Bryan Pharmaceuticals Through Its Proprietor Mr. Laxmi Kand Pal / Navneet Kand Pal & Ors.
The suit sought permanent injunction against defendants for infringing Indian Patent No. 270765 concerning Baricitinib (Barinat). The patent holder alleged that licensed companies were marketing and exporting the product outside its approved use (COVID-19) for Rheumatoid Arthritis, primarily through e-commerce platforms like Indiamart.
Pioneer Corporation v.Gulab Goel & Ors.
In a suit involving claims of trademark and copyright infringement, Pioneer Corporation and Defendant No. 8 reached an amicable settlement during the pendency of the litigation. As part of this resolution, Defendant No. 8 paid compensation to the Plaintiff. The Delhi High Court subsequently allowed the application, passing a decree of permanent injunction against Defendant No. 8 and disposing of the suit concerning that specific defendant.
Republic Technologies (Na) Llc v.Vipin Pathak Trading As M/S Pathak Impex
The Delhi High Court addressed a suit filed by Republic Technologies against Vipin Pathak regarding the alleged infringement of the 'OCB' trademark and copyright related to smoking accessories. While the court noted that the defendant acknowledged the plaintiff's rights, it also accepted the defendant's willingness to change their logo and mark. Consequently, an existing interim order was made absolute, while the matter was scheduled for further hearing after the defendant presented proposed changes.
Diageo Brands B V & Anr v.Rock And Storm Distilleries Private Limited
This case involved a dispute over the use of distinctive bottle designs and trademarks in the spirits industry. Diageo Brands sued Rock And Storm Distilleries for infringement of its registered design (No. 306577) and trademark ('Hipster', No. 4419654), alongside passing off related to trade dress. The parties ultimately reached an amicable settlement, which was subsequently recorded by the Delhi High Court.
Novartis Ag v.Windlas Biotech Pvt Ltd
Novartis initiated multiple suits against various defendants, including Windlas Biotech and Eris Lifesciences, alleging infringement of Indian Patent No. IN229051, which covers a combination drug (Valsartan + Sacubitril) used to treat cardiovascular disease. The Delhi High Court addressed applications seeking interim injunctions and access to distribution details. While the court maintained an interim injunction against manufacturing and selling the patented composition, it also directed Eris Lifesciences Limited to deposit Rs. 5 crores due to the marketing of stock post-infringement.
Sandvik Intellectual Property Ab v.Sai Deepa Rock Drills Private Limited
The plaintiffs filed a suit alleging infringement of their registered patents related to Top Hammer Rock Drilling Tools. The court passed an interim order granting a temporary injunction restraining the defendants from commercializing the infringing products and directed the defendants to disclose specific financial and production details on affidavit.
Bristol Myers Squibb Holdings Ireland Unlimited Company v.Jigs Chemical Limited & Anr.
The Plaintiff filed a suit seeking an injunction against Defendant No.1, alleging that the defendant was advertising and selling 'APIXABAN' (a patented pharmaceutical preparation) as an Active Pharmaceutical Ingredient (API). The court found a prima facie case for infringement and granted an ex parte ad interim injunction restraining the manufacturing and sale of APIXABAN.
Dealing with a patent challenge?
Whether it's a Section 3(d) rejection, a post-grant opposition, or a FRAND dispute, Arctic's patent litigation team has handled it. Get a strategy call.